Global Clinical Nutrition Market Trends and Forecast (2019-2024): High Spending on Healthcare Boosts Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
Clinical Nutrition Market- Segmented by Route of Administration,
Disease, End User, and Geography – Trends, and Forecast (2019 – 2024)”

report has been added to ResearchAndMarkets.com’s
offering.

The clinical nutrition market was valued at USD 28574.5 million in 2017,
is expected to register a CAGR of about 6.8% during the forecast period,
2018-2023.

High Spending on Healthcare Boosts the Growth of Clinical
Nutrition Market

Healthcare spending continues to grow faster than economic growth in
most countries, maintaining a trend observed over the decades. The
presence of equitable, responsive, and efficient health systems across
North American, European, and Asia-Pacific countries has also
contributed to the maximum share of GDP for healthcare expenditure.

The US government spends the highest on healthcare. In 2016, the United
States spent nearly USD 3.4 trillion on healthcare, with advanced
healthcare facilities, a high cost of treatments, and high healthcare
awareness being the major reasons. Countries, like Norway and
Switzerland, were also the next big spenders on health per capita. There
are many funding opportunities for clinical nutrition from governments
across the globe private foundations and the international community.

The major funding organizations are National Institutes of Health, the
United States Department of Agriculture, the Robert Woods Johnson
Foundation, and the Nestle Foundation. The American Society for
Nutrition organizes events, seminars, and collaborations, globally, for
the promotion of nutrition research.

The high per capita income and industrialized economy also help people
in developed countries to spend more on clinical nutrition. As
healthcare spending increases worldwide among major countries of the
world, the clinical nutrition market, because of its wide applicability,
is also set to witness a higher CAGR throughout the forecast period.

Imprecise Perception about Clinical Nutrition Hindering the
Growth of Clinical Nutrition Market

It has been observed globally that most people generally do not
understand the difference between nutrition and clinical nutrition. In
most parts of the world (other than cases where malnutrition arises due
to lack of proper food or affordability of proper food), people believe
that any malnutrition can be simply treated by making required dietary
changes. They fail to realize that malnutrition is not always due to
improper diet and can be due to many other conditions, such as nutrient
absorption disorders or metabolic syndromes.

This misconception about clinical nutrition prevents many people
(particularly from emerging and third-world countries) from even
visiting healthcare professionals or even following their instructions
and using clinical nutrition (as most people in these countries consider
clinical nutrition used only by severely ill people). These false
perceptions about malnutrition in general and clinical nutrition, in
particular, are restraining the growth of this market

Market Segmentation Insights

Insights on the route of administration; It is further segmented into
oral, enteral and parenteral. Oral clinical nutrition holds the largest
share in terms of value in this segment. Of the three routes of
administration available for clinical nutrition, oral and enteral routes
are used the most, followed by the parenteral route. This is mainly
because of the additional cost of processing the product/nutrient
involved in enteral/parenteral routes (discussed in detail in the
respective sections).

Along with this, most of the disease conditions, in which the oral route
is used for the administration of clinical nutrition, are chronic
conditions and not acute conditions. However, enteral is growing with
the highest CAGR in the market which is 7.9%, due to the low cost of
enteral administration of nutrients, which require a far lower level of
processing compared to the processing required for parenteral
administration of nutrients.

By disease type, nutritional support in gastrointestinal disease holds
the largest share in the market due to the growing prevalence of
diseases, technological advancements and active participation of major
players like Nestle, MediFood, Nutrica for the growth of nutritional
support in gastrointestinal diseases application.

However, nutritional support in neurological diseases is growing with
the highest CAGR in the market which is 8.2%, due to the high prevalence
of neurological diseases like Alzheimer disease, depression and
epilepsy. Also, major companies are targeting their products to
neurological disease.

Based on the end-user, the market is further segmented into infant,
child, adult and geriatric. The geriatric population holds the highest
share in the market which is 38% due to increasing prevalence of
geriatric population especially in North America and Europe as the
tendency for malnutrition is quite high, compared to other age groups
and presence of various disorders also creates more demand for essential
nutrients. However, infants segment is growing rapidly with a CAGR of
7.6% in the market.

Asia-Pacific to Dominate the Clinical Nutrition Market Growth

Asia-Pacific is the largest geographical market and is also expected to
register the highest CAGR of 7.9%. The factors attributing the high
growth of the Asia-Pacific are increasing investments from manufacturers
in the R&D for innovating new products with enhanced nutrition and
focused on improving the health of infants would help in the further
market expansion.

Growing awareness about the relationship between health and nutrition,
recovering market conditions would help clinical nutrition market to
succeed in the long-term. Also, in rural China malnutrition is starting
at a very early age in children and is also lasting for a very long time
which is the main reason for the largest share of China in the
Asia-Pacific clinical nutrition market.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
6.1
Market Drivers
6.2 Market Restraints
6.3 Opportunities
6.4
Key Challenges

7. Market Segmentation
7.1 Segmentation – by Route of Administration
7.2
Segmentation – by Disease Type
7.3 Segmentation – by End User
7.4
Segmentation – by Geography

8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2
Agreements, Collaborations and Partnerships
8.3 New Products
Launches

9. Key Players
9.1 Abbott Nutrition
9.2 Nestle Health Science
9.3
Baxter Healthcare
9.4 B. Braun Melsungen AG
9.5 Nutricia
9.6
Mead Johnson
9.7 Perrigo Company PLC
9.8 Fresenius Kabi

List Not Exhaustive

10. Future Market Outlook

For more information about this report visit https://www.researchandmarkets.com/research/pj39cv/global_clinical?w=4

(Excerpt) Read more Here | 2019-04-08 09:37:00
Image credit: source

LEAVE A REPLY

Please enter your comment!
Please enter your name here